NOVT250117P175000
- 0.00
- 0.000.00%
Novanta Newsroom
Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025
Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price
The Returns At Novanta (NASDAQ:NOVT) Aren't Growing
An Insider At Novanta Lowered Their Holding Recently
Novanta Insider Sold Shares Worth $660,184, According to a Recent SEC Filing
Form 144 | Novanta(NOVT.US) Insider Proposes to Sell 3.51 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 8, $Novanta(NOVT.US)$ Insider Young Brian S intends to sell 19,220 shares of its common stock on Nov 8, with a total market value of approximately $3.51 million. Source:
Shares of Companies Within the Broader Technology Sector Are Trading Higher in Sympathy With Overall Market Strength After Donald Trump Was Elected President of the United States.
Earnings Call: Novanta Reports Robust Q3 With Revenue up 10%
Novanta Is Maintained at Neutral by Baird
Novanta Analyst Ratings
Baird Maintains Novanta(NOVT.US) With Hold Rating, Cuts Target Price to $169
Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript Summary
Novanta Shares Are Trading Lower After the Company Reported Q3 Financial Results and Issued Q4 and FY24 Guidance Below Estimates.
Novanta | 10-Q: Q3 2024 Earnings Report
Novanta | 8-K: Novanta Announces Financial Results for the Third Quarter 2024
Novanta's (NASDAQ:NOVT) Q3 Sales Top Estimates But Full-Year Sales Guidance Misses Expectations
Novanta Expects FY24 Revenue Of $948M-$953M (Prior $975M) Vs $973.08M Est, Adj EPS Of $3.02-$3.06 (Prior $3.20-$3.35) Vs $3.29 Est
Express News | Novanta Inc - Sees Q4 Adjusted Diluted EPS to Be in Range of $0.70 to $0.74
Novanta Non-GAAP EPS of $0.85 In-line, Revenue of $244M Beats by $1.67M
Novanta Announces Financial Results for the Third Quarter 2024